Cite
APA Citation
Ward, R., Paltrinieri, E., Marques, M., Iyer, P., Dietrich, S., Waight, J., Bushell, M., Wilson, N., Buell, J., Savitsky, D., & Chand, D. (n.d.). 253 Anti-TIGIT antibodies require enhanced FcγR co-engagement for optimal T and NK cell-dependent anti-tumor immunity. Journal for immunotherapy of cancer, 8, A153. http://access.bl.uk/ark:/81055/vdc_100144718625.0x000002